Strategic Initiative

Slingshot members are tracking this corporate initiative:

Alpine Immune Sciences (ALPN) and Horizon Therapeutics (HZNP) Announce Exclusive License and Collaboration Agreement to Develop Novel Protein-Based Therapies for Autoimmune and Inflammatory Diseases

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
HZNP

100%
ALPN

100%
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date:
Dec 16, 2021
Projected Implementation:
Q4, 2021
Relevance Tracked Until:
Q1, 2022
Related Projects Image
  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Autoimmune Diseases, Inflammatory Disorders